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Background: Several studies have outlined a possible relationship between an increased body
mass index (BMI) and respiratory allergic diseases, such as asthma and rhinitis.
The aim of the study was to analyse the relationship between BMI and allergic diseases,
including allergic rhinitis and asthma, and functional parameters, such as nasal airflow,
FEV1, and non-specific BHR to methacholine, in a cohort of navy army subjects.
Methods: The study included 100 patients with moderateesevere persistent allergic rhinitis
alone, 100 with intermittent allergic asthma alone, and 100 healthy controls. All subjects were
evaluated performing skin prick test, spirometry, and bronchostimulation test with methacho-
line. Rhinomanometry was performed in patients with rhinitis.
Results: BMIvaluesweresignificantly lower incontrol subjectswith respect topatientswith rhinitis
(PZ 0.0002) andwith respect topatientswithasthma (P < 0.0001). BMIwasalso significantlyhigh-
er in males with respect to females (PZ 0.005). A significant relationship has been observed
between some categories of BHR and BMI either in patients with rhinitis (P < 0.01) or in patients
with asthma (P < 0.01),whereas therewas no association betweenBMI and functional parameters.
Conclusion: This study provides the first evidence of a significant relationship between BMI and
allergic rhinitis and between BMI and BHR in both allergic disorders.
ª 2008 Elsevier Ltd. All rights reserved.a e Metodologia Medica I,
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The incidence of obesity and associated co-morbidities is
dramatically increasing worldwide in both children and.
290 G. Ciprandi et al.adults.1 Obesity is characterized by a low grade systemic
inflammation. In fact, inflammatory markers, such as C-
reactive protein (CRP) and interleukin (IL)-6, are increased
in obese subjects.1 Several studies have also hypothesized
a possible relationship between an increased body mass
index (BMI) and respiratory allergic diseases such as asthma
and rhinitis.2e4 Moreover, a stronger association in women
has been reported.4e6 Nevertheless, the mechanism for the
association between respiratory allergic diseases and
obesity and the reasons for the apparent difference
between men and women remain yet unclear.2 Because
both respiratory allergic diseases and obesity are charac-
terized by inflammation, a common inflammatory pathway
has been proposed as a plausible explanation for the asso-
ciation between respiratory allergic diseases and obesity.7
The current view of adipose tissue is that of an active
secretory organ, sending out and responding to signals that
modulate appetite, energy expenditure, insulin sensitivity,
endocrine and reproductive systems, bone metabolism,
inflammation and immunity.1,8 Moreover, adipose tissue
produces adipokines such as leptin and adiponectin that
might concur to maintaining, and/or amplifying
inflammation.1,9
We hypothesized that body mass index (BMI), which is
considered a universal indicator of adiposity in according
to World Health Organization (WHO) criteria, could be
associated with allergic asthma and rhinitis. To this aim,
a cohort of navy army subjects containing 100 rhinitis
patients, 100 asthmatic patients, and 100 healthy
controls was enrolled. Therefore, we analysed the rela-
tionship between BMI and allergic diseases, including
allergic rhinitis and asthma, and functional parameters,
such as nasal airflow, FEV1, and non-specific BHR to
methacholine.
Methods
Study design
The study included patients with moderateesevere persis-
tent allergic rhinitis alone or with intermittent allergicTable 1 Demographic and clinical parameters of the study sub
Healthy subjects
NZ 100
Gender: males e N (%) 90
Age at study visit e mean [SD] 28.5 [8.1]
Smokers e N (%) 24
Body mass index e mean [SD] 24.0 [2.4]
Normal body weight e N (%) 70
Overweight e N (%) 30
Obese e N (%) 0
BHR positive e N (%) 0
Indoor allergens sensitization e N (%) e
Outdoor allergens sensitization e N (%) e
Ineoutdoor allergens sensitization e N (%) e
a Fisher’s Exact test.asthma alone. It is to consider that persistent asthma is
unfitting with military service. All subjects were consecu-
tively enrolled from April to June 2007 until the previously
calculated needed sample of 100 subjects per arm was
reached. All subjects were evaluated performing skin prick
test, spirometry, and bronchostimulation test with meth-
acholine. Rhinomanometry was performed in patients with
rhinitis.
Subjects
Three hundred subjects were included in the study: 257
males and 43 females. The mean age was 25 years (SD:
6.5 years). One hundred subjects had moderateesevere
persistent allergic rhinitis without asthma and with mean
disease duration of 5 years (SD: 3.3 years); one hundred
subjects had intermittent allergic asthma without rhinitis
and with mean disease duration of 7.1 years (SD: 4.5 years);
one hundred subjects were healthy subjects. Demographic
characteristics, including gender, age, smoking, BMI, over-
weight and obesity, BHR, and type of are reported in Table 1.
All of them were Navy soldiers who had to refer to Navy
Hospital for mandatory periodic visit for maintaining the
qualification. An informed consent was obtained from each
patient.
A detailed clinical history was taken and a complete
physical examination was performed. The patients were
included in the study on the basis of a clinical history of: (i)
persistent allergic rhinitis and presence of moderatee
severe nasal symptoms according to validated criteria10; or
(ii) intermittent allergic asthma on the basis of validated
diagnostic criteria.11 Exclusion criteria were: acute or
chronic upper respiratory infections, anatomical nasal
disorders (i.e. nasal polyps, septum deviation, etc.),
previous or current specific immunotherapy, use of nasal
steroids in the current pollen season, and use of inhaled
short acting beta agonists and antihistamines during the
previous week. All patients assumed only short acting beta
agonists or oral antihistamines on demand.
The diagnosis of persistent allergic rhinitis and inter-
mittent allergic asthma were made on the basis of a historyjects.
Allergic rhinitis
NZ 100
Allergic asthma
NZ 100
P Total
NZ 300
76 91 0.003 257 (85.7)
24.6 [4.9] 22.0 [4.0] <0.0001 25.0 [6.5]
9 3 <0.0001 36 (12.0)
25.5 [2.6] 26.0 [2.8] <0.0001 25.2 [2.7]
41 35 <0.0001a 146 (48.7)
57 60 147 (49.0)
2 5 7 (2.3)
64 100 <0.0001 164 (54.7)
11 21 0.011 32 (16)
24 10 34 (17)
65 69 134 (67)
BMI and respiratory allergic diseases 291of upper or lower respiratory symptoms and positive skin
prick test according to validated criteria.10,11
Skin prick test
It was performed as stated by the European Academy of
Allergy and Clinical Immunology.12 The panel of employed
allergens consisted of: house dust mites (Dermatopha-
goides farinae and pteronyssinus), cat, dog, grasses mix,
Compositae mix, Parietaria officinalis, birch, hazel, olive
tree, Alternaria tenuis, Cladosporium, Aspergilli mix
(Stallergenes, Milan, Italy).
Spirometry
It was performed with a computer-assisted spirometer
(Pulmolab 435-spiro 235, Morgan, England) and according to
international guidelines.13,14 Briefly, three blows (every
5 min) were performed and the best result was considered.
All subjects met the criteria for reproducibility and
acceptability.
Methacholine bronchial challenge
It was performed to evaluate BHR when basal FEV1 was
equal or more than 80% of predicted values. Aerosol is
delivered using a dosimetric computerized supply (MEFAR
MB3, Marcos, Italy). Subjects inhaled increasing doses of
methacholine, starting from 30 mg. The scheduled doses
consisted of the following: 30, 30, 30, 60, 90, 150, 150, 300,
300, 300, 150 mg as previously reported.15
The test was interrupted and considered positive when
FEV1 value diminished by more or equal than 20% of control
or a maximal cumulative methacholine dose of 1590 mg was
achieved. The threshold dose causing a 20% fall of FEV1
(PD20) was calculated.
Degree of BHR
Four arbitrary categories of BHR were considered on the
basis of PD20: very severe PD20 <100 mg; severe PD20
between 100 and 349 mg; moderate PD20 ranging from 350
to 649 mg, and mild PD20 between 650 and 1590 mg as
previously reported.15 Subjects without response to the
cumulative dose of 1590 mg were considered without BHR.
Statistical analysis and data definitions
Descriptive statistics were firstly performed and quantita-
tive parameters were reported as means and standard
deviations (SD), or as medians with first and third quartiles
[1ste3rd quartiles] in case of skewed distribution. Quali-
tative data were reported as absolute frequencies and
percentages. Comparison of qualitative variables among
groups of subjects was made by the chi-square test; post-
hoc comparison of percentages has been made by means of
Bonferroni’s correction (PB). Comparison of quantitative
variables between two groups of subjects (males vs
females) was made by means of the non-parametric Manne
Whitney U-test due to the skewed distributions of the
variables or to the absence of homoscedasticity.Comparison of quantitative variables among different
groups of subjects (ex.: patients with rhinitis vs patients
with asthma vs control subject long-lasting rhinitis) was
made by means of the parametric analysis of variance
(ANOVA) in case of normally distributed data or by means of
the non-parametric KruskaleWallis test in case of skewed
distributions; Sheffe´ test was chosen as the parametric
post-hoc test, and the Dunn’s test was used as the non-
parametric post-hoc test. A two-way analysis of variance
has been performed in order to simultaneously evaluate the
effect of gender and of different groups of patients on BMI
values.
Correlation between quantitative variables was evalu-
ated by means of the Pearson’s correlation coefficient (r).
Finally, a multivariate logistic regression analysis was
used to evaluate the role of different independent
explanatory variables for the condition of being an over-
weight/obese subject. The three explanatory variables
were: gender, BHR positivity, and diagnosis. Odd ratios with
95% confidence intervals (95% CI) were calculated using
a backward procedure. Statistical significance of the vari-
ables included in the models was tested by means of the
likelihood ratio test (LR test).
All tests were two sided and a P value less than 0.05 was
considered statistically significant. The statistical package
Statistica (StatSoft Corp., Tulsa, OK) was used for univar-
iate analyses and the Stata release 7 (Stata Corporation,
TX) for multivariate analyses.
Results
Three hundred patients, 257 males and 43 females, were
included in the study. A complete description of the three
groups of subjects is reported in Table 1. As also shown in
Figure 1A, BMI values were significantly lower in control
subjects (mean: 24.0; SD: 2.4) with respect to patients with
rhinitis (mean: 25.5; SD: 2.6; PZ 0.0002) and with respect
to patients with asthma (mean: 26.0; SD: 2.8; P < 0.0001).
In addition, Table 1 shows that the number of smokers is
significantly higher in normal subjects (24) than in both
patients with rhinitis (9) and asthma (3) (P < 0.0001). All
asthmatics have BHR, and 64 rhinitics have BHR. Indoor
allergens sensitization is more frequent in patients with
asthma, whereas outdoor allergens sensitization is more
frequent in patients with allergic rhinitis (PZ 0.011).
Table 2 reports demographic and clinical parameters of
the three groups of subjects by gender: BMI is significantly
higher in healthy males with respect to healthy females
(PZ 0.02), in rhinitics males with respect to rhinitics
females (PZ 0.0004), whereas there is no difference in
asthmatics. Figure 1B confirms these results, using the two-
ways ANOVA analyzing the effect of gender (PZ 0.005).
Analogously the percentage of overweight/obese
subjects is significantly higher in patients with asthma (65%)
and rhinitis (59%) with respect to control subjects (30%)
(PB < 0.0001 and PBZ 0.0001, respectively).
No correlation is observed between BMI values and nasal
airflow values (ml/s) (rZ 0.19) in patients with rhinitis
and no correlation is observed between BMI values and
FEV1 (% of predicted) (rZ 0.08) in patients with asthma.
A clear relationship is observed between categories of
BHR and BMI either in patients with rhinitis (Figure 2A) or in
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Figure 1 BMI mean values in different groups of subjects:
control subjects, patientswith rhinitis, andwith asthma (panel A);
Pvaluesover theboxes refer to theScheffe´ test;BMImeanvalues in
different groups of subjects and by gender (panel B).
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with rhinitis (Figure 2A), BMI is significantly higher in
patients with PD20 values <100 (mean BMI: 28.1; SD: 0.5)
and in patients with PD20 values between 100 and 350
(mean BMI: 26.9; SD: 2.7) with respect to patients without
BHR values (mean BMI: 24.3; SD: 2.1) (both P values <0.01).
Moreover, in patients with asthma (Figure 2B), BMI is
significantly higher in patients with PD20 values <100
(mean BMI: 27.9; SD: 2.7) with respect to patients with
PD20 values between 100 and 350 (mean BMI: 25.3; SD: 2.6)
(P < 0.01).
Among patients with rhinitis or asthma, the percentage
of overweight/obese subjects is not associated tomono- or
poly-sensitizations: in fact the percentage of overweight/
obese subjects is 65.3% (32/49) among mono-sensitized
patients and 69.3% (92/151) among poly-sensitized
patients (PZ 0.58). Analogously there is no association
between type of sensitization (indoor, outdoor or ine
outdoor allergens) and percentage of overweight/obese
subjects; in fact the percentage of overweight/obese
subjects is 60.4% (81/134) among patients sensitized to
indoor allergens, 64.7% (22/34) among patients sensitized
to outdoor allergens, and 65.6% (21/32) among patients
sensitized to ineoutdoor allergens (PZ 0.84).
A multivariate logistic regression model was used to
evaluate the role of different independent explanatoryvariables for the condition of being an overweight/obese
subject; the only variable that turned out to be associated
with the condition of overweight/obesity is the BHR posi-
tivity (OR: 4.5; 95%CI: 2.8e7.4) (LR-test; P < 0.0001); the
other two variables (diagnosis and gender) are not
confirmed as important predictors of overweight/obesity
when analyzed in the multivariate model (PZ 0.29 and
PZ 0.06, respectively).
Discussion
There is evidence that the prevalence of allergic disorders,
such as rhinitis and asthma, has worldwidely increased in
developed countries.16 Even though several environmental
factors have been hypothesized to be involved in the
development of allergic diseases, none could fully explain
the rapid increase of the prevalence. However, some life-
style factors, including dietary factors, alcohol consump-
tion, physical inactivity, and obesity, have recently
obtained distinctive regard. Indeed, the increase in afflu-
ence, typical of western society, may result in increased
availability of foods and decreased physical activities, both
of them may contribute to promote the prevalence of
obesity and overweight. In addition, there is evidence that
obesity and overweight are linked with allergic diseases
probably because of the immunogical effects of adipose
tissue on the development of allergies. Obesity has been
associated with an increased risk of asthma both in children
and adults.17,18 However, the real association between
obesity and allergic disorders is unclear. Many cross-
sectional surveys pointed out that obesity is a risk factor for
asthma. Moreover, a gender-dependant influence was
observed and a significant association between body fat
and asthma in women but not in men was found.2
A recent meta-analysis of prospective epidemiological
studies concerning the relationship between obesity and
asthma has been recently published.19 Most of them evi-
denced that obesity was a risk factor for the development
of asthma (OR ranging between 1.1 and 3.0) and that
obesity preceded the development of asthma.3 However,
the studies including lung function assessment showed
conflicting results. One study evidenced an increased risk of
bronchial hyperreactivity in obese patients.20 In contrast,
another study provided evidence of lower risk of BHR21 and
another survey reported less airflow obstruction in obese
patients,22 even though obese patients reported more
respiratory complaints and used more bronchodilator drugs
than normal-weight patients.
Other relevant issue is the relationship between BMI and
allergic disorders: some studies reported a positive associ-
ation even if not consistent, mainly concerning the gender
relevance.23e27 BMI would seem to be an independent risk
factor for allergy in females, but not in males. However, it
is to note that not all studies found a greater association
between BMI and asthma in women than in men. In addi-
tion, most of these studies have been relied on self-
reported height and weight.
Moreover, only two studies investigated the effects of
obesity on allergic rhinitis. The first study, conducted on
a large cohort of 1,247,038 Swedish military conscripts,
reported that obesity was not associated with allergic
rhinitis in patients with nasal symptoms only.4 The second
Table 2 Demographic and clinical parameters of the three groups of subjects by gender.
Males Females P
Healthy subjects (NZ 90) (NZ 10)
Age at study visit e median [1ste3rd quartiles] 27 [24e29] 28.5 [24e42] 0.50a
Smokers e N (%) 23 (25.6) 1 (10.0) 0.44c
Body mass index e median [1ste3rd quartiles] 23.7 [22.9e25.5] 22.4 [19.6e24.0] 0.02a
Overweight e N (%) 28 (31.1) 2 (20.0) 0.72c
Allergic rhinitis (NZ 76) (NZ 24)
Age at study visit e median [1ste3rd quartiles] 24 [21.5e26.0] 23 [21.0e24.5] 0.05a
Smokers e N (%) 7 (9.2) 2 (8.3) 1.00c
Body mass index e median [1ste3rd quartiles] 26.6 [24.3e27.7] 23.3 [22.2e25.8] 0.0004a
Overweight or obese e N (%) 49 (64.5) 10 (41.7) 0.05b
BHR positive e N (%) 46 (60.5) 18 (75.0) 0.20b
Indoor allergens sensitization e N (%) 11 (14.5) 0 (0.0) 0.05c
Outdoor allergens sensitization e N (%) 20 (26.3) 4 (16.7)
Ineoutdoor allergens sensitization e N (%) 45 (59.2) 20 (83.3)
Allergic asthma (NZ 91) (NZ 9)
Age at study visit e median [1ste3rd quartiles] 21 [19e24] 23 [22e25] 0.06a
Smokers e N (%) 3 (3.3) 0 (0.0) 1.00c
Body mass index e median [1ste3rd quartiles] 25.6 [24.1e28.1] 25.5 [23.3e28.0] 0.89a
Overweight or obese e N (%) 59 (64.8) 6 (66.7) 1.00c
Indoor allergens sensitization e N (%) 21 (23.1) 0 (0.0) 0.26c
Outdoor allergens sensitization e N (%) 9 (9.9) 1 (11.1)
Ineoutdoor allergens sensitization e N (%) 61 (67.0) 8 (88.9)
a ManneWhitney U-test.
b Chi-square test.
c Fisher’s Exact test.
BMI and respiratory allergic diseases 293study evidenced that the risk of allergic rhinitis increased
with increasing BMI among women but not among men.28
On the other hand, the association between obesity and
respiratory allergy may, at least partially, depend on
decreased immunological tolerance to allergen as a conse-
quence of immunological changes induced by adipokines,
such as adiponectin and leptin, and some pro-inflammatory
cytokines, including IL-6 and TNF-a, secreted by WAT.
However, two recent studies demonstrated the absence of
a significant association between body fat and airway
inflammation in both sexes.2,29
On the basis of these data, the present study was
designed to analyse the relationship among BMI, nasal
airflow, FEV1, and non-specific bronchial hyperreactivity to
methacholine in patients with allergic asthma or rhinitis.
This study was conducted on a well selected and evaluated
group of subjects: all subjects were processed to skin prick
test, spirometry, broncostimulation test with methacho-
line, and rhinomanometry (rhinitics alone). In addition, all
patients were allergic.
Firstly, this study provides evidence of a global signifi-
cant association between BMI and both allergic rhinitis and
asthma. Considering the gender, a different association
pattern was evident: allergic rhinitis was associated with
increased BMI only in males, whereas allergic asthma was
associated with increased BMI in both genders. This finding
confirms the positive studies reported in literature about
the association between asthma and obesity in females,
and provides the first evidence of a significant association
between increased BMI and allergic rhinitis in males. Thisfinding is conflicting with previous studies.27,28 However,
both studies were conducted considering a diagnosis made
by questionnaires without performing clinical visit and
functional tests. Thus, there was less accuracy of data in
those surveys in comparison with the present study. More-
over, the mean BMI is relatively increased, it may depend
on the particular case study represented by trained,
substantially healthy, and continuously checked people as
Navy soldiers.
The second relevant outcome is the absence of a rela-
tionship between BMI and both nasal airflow and bronchial
function. This finding underlines the fact that the possible
mechanisms of association between obesity and respiratory
allergy should not depend on mechanical consequences
linked with fat build up, but might be likely related to
immunological changes induced by adipokines and cyto-
kines secreted by adipose tissue.
The third interesting result is the significant association
between BMI and BHR in both allergic rhinitis and asthma.
Even though a different behavior exists in the two disor-
ders, the relationship is more evident in patients with most
severe BHR. First of all, this finding is the first evidence of
a relationship between BMI and BHR in allergic rhinitis,
which is also related with the severity of BHR. In addition,
overweight-obesity represents a relevant risk factor for
BHR (ORZ 4.5). On the other hand, the possible limitations
of this study may be: the mild severity of asthma, the
restricted number of patients, and the disproportion
between genders. Persistent asthma is unsuited with active
duty. About the adequacy of the number of patients, it was
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Figure 2 BMI mean values in different groups of subjects
according to MCH-PD20 values in patients with rhinitis (panel A)
and in patients with asthma (panel B). P values inside the figure
refer to the non-parametric Dunn’s test.
294 G. Ciprandi et al.previously calculated the consistency of the sample: this
cohort assures the statistical significance of the findings.
However, the difference between males and females is too
big to allow any definitive conclusion on the gender effect
and it constitutes a limitation of this study. In fact, this
study failed to find any association between allergic rhinitis
and BMI in women because of the low number of females. In
addition, this was a group of well-trained navy soldiers; this
may mean that muscle part is more represented than in
normal population. However, a control group of healthy
sailors has been considered in the study design to partially
avoid this bias.
Moreover, it is important to underline the fact that
allergic rhinitis is to consider as a risk factor for both BHR
and asthma as it may precede asthma30 and hence it may
account for the relationship between allergic rhinitis and
BMI.
In conclusion, this study provides the first evidence of
a significant relationship between BMI and allergic rhinitis
and between BMI and BHR in both allergic disorders.
Further studies should be addressed to investigate the role
of the adipokines in the pathogenesis of these
relationships.Conflict of interest statement
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